GW Pharmaceuticals (GWPH)
97.33
-0.24 -0.25%
NASDAQ
Jun 28, 20:00
Delayed 2m
USD
View All Key Stats
GWPH Key Stats
| Income Statement | |
| Revenue (TTM) | 10.11M |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -4.146 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -101.69M |
| Profitability | |
| Gross Profit Margin (Quarterly) | 57.78% |
| Profit Margin (Quarterly) | -2.11K% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | 0.00 |
| Price and Valuation | |
| Market Cap | 2.465B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | 233.50 |
| PE Ratio (TTM) | -- |
| Price to Book Value | 5.578 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Quarterly) | 0.00 |
| Free Cash Flow (Quarterly) | -61.60M |
| Return on Equity (TTM) | -25.21% |
View All GWPH News
GWPH News
-
WireHeadlineTime (ET)
-
Yahoo06/25 09:03
-
Yahoo06/24 09:13
-
Yahoo06/23 16:40
-
Yahoo06/23 14:31
-
MT Newswires06/23 10:49
-
PR Newswire06/22 08:45
-
Yahoo06/21 08:00
-
Yahoo06/20 15:02
-
MT Newswires06/20 10:57
-
MT Newswires06/19 12:05
View All Events
GWPH Events
| Date | Type | Description |
|---|---|---|
| 05/09/2017 16:30 EDT | Misc | GW Pharmaceuticals PLC Second Quarter Earnings Conference Call in 2017 |
| 05/09/2017 | Earnings | GW Pharmaceuticals PLC Second Quarter Earnings in 2017 Release |
| 04/22/2017 | Misc | GW Pharmaceuticals PLC Annual General Meeting in 2016 |
| 02/07/2017 08:30 EST | Misc | GW Pharmaceuticals PLC First Quarter Earnings Conference Call in 2017 |
| 02/07/2017 | Earnings | GW Pharmaceuticals PLC First Quarter Earnings in 2017 Release |
| 12/20/2016 | Misc | GW Pharmaceuticals PLC Annual Report in 2016 |
| 12/05/2016 08:00 EST | Misc | GW Pharmaceuticals PLC Fourth Quarter Earnings Conference Call in 2016 |
| 12/05/2016 | Earnings | GW Pharmaceuticals PLC Fourth Quarter Earnings in 2016 Release |
| 08/09/2016 08:30 EDT | Misc | GW Pharmaceuticals PLC Third Quarter Earnings Conference Call in 2016 |
| 08/09/2016 | Earnings | GW Pharmaceuticals PLC Third Quarter Earnings in 2016 Release |
GWPH Fundamentals
Income Statement View Statement
GWPH Ratings
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
Advertisement
GWPH One Page Reports
- One Page Report Download
GWPH Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Target Price | |
| Price | 97.33 |
| Price Target | Upgrade |
Edit
Profile
- URL: http://www.gwpharm.com
- Investor Relations URL: http://ir.gwpharm.com/
- HQ State/Province: N/A
- Sector: Healthcare
- Industry: Drug Manufacturers - Major
- Next Earnings Release: N/A
- Last Earnings Release: May. 09, 2017
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: GW Pharmaceuticals PLC is engaged in the research, development and commercialisation of cannabinoid prescription medicines using botanical extracts derived from the Cannabis Sativa plant.
GWPH Comparables
EditGWPH Excel Add-In Codes
- Name: =YCI("GWPH","name")
- Description: =YCI("GWPH","description")
- Sector: =YCI("GWPH","sector")
- Industry: =YCI("GWPH","industry")
- Est. Current Fiscal Year End: =YCI("GWPH","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other GWPH Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- GWPH Tweets Stocktwits
Advertisement
